cobas SARS-CoV-2 & Influenza A/B Qualitative nucleic acid test for use on the cobas 5800/6800/880...

FDA Recall #Z-1105-2023 — Class II — December 21, 2022

Recall #Z-1105-2023 Date: December 21, 2022 Classification: Class II Status: Ongoing

Product Description

cobas SARS-CoV-2 & Influenza A/B Qualitative nucleic acid test for use on the cobas 5800/6800/8800 Systems; Material Number 09446125190

Reason for Recall

The firm received customer complaints regarding false negative Influenza A (Flu A) results and late Flu A Target Ct values. A false negative influenza A result may lead to additional testing, psychological distress, and delays to targeted therapy for influenza as well as true diagnosis.

Recalling Firm

Roche Molecular Systems, Inc. — Branchburg, NJ

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Devices

Product Quantity

9,948 OUS only

Distribution

Domestic distribution nationwide. Foreign distribution worldwide.

Code Information

UDI-DI 00875197006827 All in-date lots

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated